To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission
Study limitation reported by the research below: “Survey-based study design reflects physician opinions and practice patterns rather than clinical outcomes data, limiting direct applicability to patient management decisions.”